| dc.description.abstract | Background --- The assessment of level severity in patient with acute
exacerbation COPD (AECOPD) is very important to determine the risk of
inhospital mortality, requirement ICU setting and next management of disease.
Several strongest predictors of mortality such as eosinophil, blood gas analysis,
renal function test and other measurement were combined, to assess of level
severity. The application of DECAF score and BAP-65 score is known to be used
in prediction of mortality, to help clinician to decide treatment and to make
prognosis. DECAF score performed significantly better for prediction of mortality
than BAP-65 score.
Objective --- To determine comparison between DECAF score and BAP-65 score
to predict 30 days-mortality in AECOPD patients
Materials and Methods --- This was an cohort study. We had examined
AECOPD subject with DECAF score (Dyspnoea, Eosinopenia, Consolidation,
Acidaemia, Atrial Fibrillation) and BAP-65 score (Elevated BUN, Altered mental
status, Pulse l 09 beats/min, Age > 65 years), other laboratory assessment,
spirometry, chest X-ray and ECG at the early admission at emergency room (ER).
We had calculate sensitivity and specificity of DECAF score and BAP-65 score
and compare the strongest predictor to predict 30-days mortality to determined
prognostic utility of this score.
Result-- 40 subject were recruited, mean(± SD) age was 61,07 ± 12,42 years,
75% subjects were male, and 9 subject died during the study. This study
performed significantly result of DECAF score p value 0,003 {p < 0,05) and BAP-
65 score p value 0,0026 (p < 0,05) to predict 30-days mortality in AECOPD,
using chi square test. Sensitivity and specificity DECAF score were I 00% and
16%, sensitivity and specitifity BAP-65 score were I 00% and 39%.
Conclusion --- DECAF score and BAP-65 score have correlation with 30-days
mortality in AECOPD patients. High sensitivity and low specificity made this
score have not been used to predict 30-days mortality and prognostic tools. | en_US |
